These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16220064)

  • 41. Possible beneficial effect of olmesartan medoxomil on left atrial function in patients with hypertension : noninvasive assessment by acoustic quantification.
    Gong HP; Zhang W; Li L; Tan HW; Ma ZY; Zhong XZ; Wang ZH; Song T; Zhang Y; Zhong M
    Clin Drug Investig; 2008; 28(4):241-9. PubMed ID: 18345714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renoprotective effects of blockade of angiotensin II AT1 receptors in an animal model of type 2 diabetes.
    Mizuno M; Sada T; Kato M; Koike H
    Hypertens Res; 2002 Mar; 25(2):271-8. PubMed ID: 12047043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of 24-h ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate.
    Chrysant SG; Marbury TC; Silfani TN
    Blood Press Monit; 2006 Jun; 11(3):135-41. PubMed ID: 16702822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between the frequency of blood pressure self-measurement and blood pressure reduction with antihypertensive therapy : results of the OLMETEL (OLMEsartan TELemonitoring blood pressure) study.
    Ewald S; vor dem Esche J; Uen S; Neikes F; Vetter H; Mengden T
    Clin Drug Investig; 2006; 26(8):439-46. PubMed ID: 17163276
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Olmesartan medoxomil plus hydrochlorothiazide for treating hypertension.
    Barrios V; Escobar C
    Expert Opin Pharmacother; 2008 Jan; 9(1):129-36. PubMed ID: 18076344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and pharmacotherapeutic relevance of the double-chain domain of the angiotensin II type 1 receptor blocker olmesartan.
    Kiya Y; Miura S; Fujino M; Imaizumi S; Karnik SS; Saku K
    Clin Exp Hypertens; 2010 Jan; 32(2):129-36. PubMed ID: 20374187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
    Igase M; Yokoyama H; Ferrario CM
    Ther Adv Cardiovasc Dis; 2011 Dec; 5(6):297-304. PubMed ID: 22089474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
    Le MT; Pugsley MK; Vauquelin G; Van Liefde I
    Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
    Smith RD; Yokoyama H; Averill DB; Cooke L; Brosnihan KB; Schiffrin EL; Ferrario CM
    Am J Cardiovasc Drugs; 2006; 6(5):335-42. PubMed ID: 17083268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olmesartan medoxomil.
    Warner GT; Jarvis B
    Drugs; 2002; 62(9):1345-53; discussion 1354-6. PubMed ID: 12076183
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of angiotensin receptor blockers on ambulatory plasma Renin activity in healthy, normal subjects during unrestricted sodium intake.
    Jones MR; Sealey JE; Laragh JH
    Am J Hypertens; 2007 Aug; 20(8):907-16. PubMed ID: 17679042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
    Mallion JM; Heagerty A; Laeis P
    J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
    Rump LC; Sellin L
    Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological and pharmacokinetic study of olmesartan medoxomil in animal diabetic retinopathy models.
    Nakamura H; Inoue T; Arakawa N; Shimizu Y; Yoshigae Y; Fujimori I; Shimakawa E; Toyoshi T; Yokoyama T
    Eur J Pharmacol; 2005 Apr; 512(2-3):239-46. PubMed ID: 15840410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Review of Olmesartan-based Therapy in Targeting Effective Blood Pressure Control and Achieving Blood Pressure Goals.
    Tiwaskar M; Mehta KK; Kasture P
    J Assoc Physicians India; 2024 Mar; 72(3):75-78. PubMed ID: 38736121
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG; Marbury TC; Robinson TD
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Medication of the month. Olmesartan medoxomil hydroclorothiazide (Olmetec Plus or Belsar Plus].
    Lancellotti P
    Rev Med Liege; 2007 Mar; 62(3):175-9. PubMed ID: 17511387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
    Kereiakes DJ; Neutel JM; Punzi HA; Xu J; Lipka LJ; Dubiel R
    Am J Cardiovasc Drugs; 2007; 7(5):361-72. PubMed ID: 17953475
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Olmesartan, an angiotensin II receptor blocker inhibits the progression of cataract formation in cadmium chloride induced hypertensive albino rats.
    Choudhary R; Bodakhe SH
    Life Sci; 2016 Dec; 167():105-112. PubMed ID: 27744053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.